2024 NHLBI Workshop Charts Promising Future Directions for ECMO-Induced Coagulopathy
Jerrold Levy, MD, Critical care physician in CTICU, Duke University School of Medicine, recently shared an insightful post on X:
”ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (workshop NHLBI report). This open access 2024 summary is online and new ASH journal (BLOODVTH) not on PubMED yet. Extracorporeal Life Support Organization (ELSO) please share with your community.”
Read the full article here.
The NHLBI hosted a May 2024 workshop on ECMO-induced coagulopathy, uniting experts to tackle anticoagulation challenges and advance precision medicine approaches.
The event highlighted research gaps, innovative therapies, and opportunities for interdisciplinary collaboration to improve patient outcomes.
More news on scientific advancements in Hemostasis Today.
-
Sep 6, 2026, 16:41Christina (Tina) P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size
-
Sep 6, 2026, 16:23Kevin Buda: Many High-Risk PE Patients Have Contraindications to Thrombolysis
-
Sep 6, 2026, 16:16Venk Murthy: 2018 vs 2026 ACC/AHA Lipid Guidelines – A Shift From RCTs to Expert Opinion?
-
Sep 6, 2026, 16:11Silmara Montalvão: Improving Global Hemophilia Diagnostics Through Sustained External Quality Assessment
-
Sep 6, 2026, 14:50Mohamed F Doheim: Unraveling the Symphony of Stroke Management
-
Sep 6, 2026, 14:47Ahmed Bennis: E-Cigarette Use and Early Cardiovascular Risk in Young Adults
-
Sep 6, 2026, 14:46William Wallace: Iron Deficiency Can be Present Before Hemoglobin Falls and Before Anemia Appears
-
Sep 6, 2026, 14:15Listening to One Another Drives Innovation and Better Therapies in Hemophilia Care – Global Hemophilia Report